Class IOngoingD-0083-2025
Drug recall · December 11, 2024
VitalityXtra Capsules recall
Why: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com
- Lots / codes
Lot #: 230811, Exp: 08/11/2025
- Quantity
- Unknown
- Company
- Boulla LLC, Sacramento, CA
- Distribution
- Nationwide within the United States
- Initiated
- November 4, 2024 · Voluntary: Firm initiated
- Classified
- December 2, 2024
- Reported
- December 11, 2024
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.